Ube, Japan

Akishi Ninomiya

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Ube Corporation, Ube Industries, Inc.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akishi Ninomiya. Retrieved from https://idiyas.com/inventor/akishi-ninomiya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 75.0

 

Average Co-Inventor Count = 10.3

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Akishi Ninomiya - Innovations in Guanidine Compounds

Introduction

Akishi Ninomiya, based in Ube, Japan, is a distinguished inventor known for his significant contributions to the field of chemistry. With a total of three patents to his name, Ninomiya has focused his research on developing innovative substituted guanidine compounds. His work has implications in pharmaceutical sciences, showcasing his commitment to advancing medical therapies.

Latest Patents

Among his latest inventions, Akishi Ninomiya has patented a compound characterized by general formula (I), where certain variables are defined within the patent claims. This invention includes pharmacologically acceptable salts of the compound as well as pharmaceutical compositions containing it. This particular innovation has the potential to impact various therapeutic applications, improving patient outcomes in medicine.

Career Highlights

Ninomiya has had a notable career with prominent companies such as Ube Corporation and Ube Industries, Inc. His experiences in these organizations have allowed him to refine his expertise in developing chemical compounds, significantly contributing to drug formulation and enhancement.

Collaborations

Throughout his career, Akishi Ninomiya has collaborated with esteemed colleagues, including Ken-ichi Komori and Masaru Shinohara. Working alongside these industry professionals has enabled him to engage in innovative projects and expand the possibilities within his field.

Conclusion

In summary, inventor Akishi Ninomiya has made remarkable strides in the development of substituted guanidine compounds, evidenced by his patents and collaborations within the industry. His work not only reflects his dedication as an inventor but also his impact on the pharmaceutical field, illustrating the vital role of innovation in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…